How previous treatment changes the metabolomic profile in patients with metastatic breast cancer

PURPOSE: Metabolites are in the spotlight of attention as promising novel breast cancer biomarkers. However, no study has been conducted concerning changes in the metabolomics profile of metastatic breast cancer patients according to previous therapy. METHODS: We performed a retrospective, single-ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Nees, Juliane, Schafferer, Simon, Yuan, Baowen, Tang, Quiqong, Scheffler, Matthias, Hartkopf, Andreas, Golatta, Michael, Schneeweiß, Andreas, Burwinkel, Barbara, Wallwiener, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633507/
https://www.ncbi.nlm.nih.gov/pubmed/35467121
http://dx.doi.org/10.1007/s00404-022-06558-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633507/
https://www.ncbi.nlm.nih.gov/pubmed/35467121
http://dx.doi.org/10.1007/s00404-022-06558-5

Ejemplares similares